XML 23 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statement of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Stock Options
Common stock
Additional paid-in capital
Accumulated deficit
Beginning balance (in shares) at Mar. 31, 2019     14,739,000    
Beginning balance at Mar. 31, 2019 $ 180,764   $ 1 $ 349,039 $ (168,276)
Issuance of stock during July 2019 follow-on offering, net of closing costs (in shares)     2,222,000    
Issuance of stock during July 2019 follow-on offering, net of closing costs 94,244   $ 1 94,243  
Equity based compensation (in shares) [1]     124,000    
Equity based compensation [1] 5,826     5,826  
Stock option exercises (in shares)     113,000    
Stock option exercises 2,436     2,436  
Shares withheld for taxes (in shares)     (13,000)    
Shares withheld for taxes (566)     (566)  
Net loss (37,638)       (37,638)
Ending balance (in shares) at Mar. 31, 2020     17,185,000    
Ending balance at Mar. 31, 2020 245,066   $ 2 450,978 (205,914)
Equity based compensation (in shares) [1]     249,000    
Equity based compensation [1] 16,121     16,121  
Stock option exercises (in shares)     208,000    
Stock option exercises 4,218     4,218  
Equity payment of prior year accrued employee related expenses (in shares)     28,000    
Equity payment of prior year accrued employee related expenses 1,537     1,537  
Net loss (54,434)       (54,434)
Ending balance (in shares) at Mar. 31, 2021     17,670,000    
Ending balance at Mar. 31, 2021 212,508   $ 2 472,854 (260,348)
Equity based compensation (in shares) [1]     226,000    
Equity based compensation [1] 13,725     13,725  
Stock option exercises (in shares)   822,750 778,000 [2]    
Stock option exercises [2] 15,004     15,004  
Shares withheld for taxes (in shares)     (24,000)    
Shares withheld for taxes (1,458)     (1,458)  
Retirement of common stock (in shares) [2]     (272,000)    
Retirement of common stock [2] (15,962)       (15,962)
Net loss (37,519)       (37,519)
Ending balance (in shares) at Mar. 31, 2022     18,378,000    
Ending balance at Mar. 31, 2022 $ 186,298   $ 2 $ 500,125 $ (313,829)
[1] Includes restricted shares issued.
[2] Includes approximately $1.0 million, or 20,132 shares, received associated with a non-cash exercise of stock options and subsequent retirement. See Note 11 Stock Acquisition Rights, Stock Options and Warrants and Note 12 Supplemental Disclosure of Cash Flow Information for further discussion and disclosure.